Radiologic Clinics of North America Vol 47 No 5 2009

Contrast-Induced Nephropathy and Nephrogenic Systemic Fibrosis; 2009
pp. 783-788
Contrast-Induced Acute Kidney Injury (CIAKI).
Solomon, R.
pp. 789-800
Contrast-Induced Nephropathy after Intravenous Administration: Fact or Fiction?.
Katzberg, R.W.; Lamba, R.
pp. 801-812
Prevention of Contrast-Induced Nephropathy: An Overview.
Ellis, J.H.; Cohan, R.H.
pp. 813-826
Carbon Dioxide in Angiography to Reduce the Risk of Contrast-Induced Nephropathy.
Hawkins, I.F.; Cho, K.J.; Caridi, J.G.
pp. 827-832
Nephrogenic Systemic Fibrosis: History and Epidemiology.
Thomsen, H.S.
pp. 833-840
Nephrogenic Systemic Fibrosis: Clinical Picture and Treatment.
Marckmann, P.; Skov, L.
pp. 841-854
Nephrogenic Systemic Fibrosis: Histology and Gadolinium Detection.
Thakral, C.; Abraham, J.L.
pp. 855-870
Involvement of Gadolinium Chelates in the Mechanism of Nephrogenic Systemic Fibrosis: An Update.
Idee, J.-M.; Port, M.; Dencausse, A.; Lancelot, E.; Corot, C.
pp. 871-876
How to Avoid Nephrogenic Systemic Fibrosis: Current Guidelines in Europe and the United States.
Thomsen, H.S.